Estrogen partially down-regulates PTEN to prevent apoptosis in VSC4.1 motoneurons following exposure to IFN-γ

Brain Research

Volumn 1301, Issue , 2009, Pages 163-170

  Smith, Joshua A ^a   Zhang, Ran ^a   Varma, Abhay K ^a   Das, Arabinda ^a   Ray, Swapan K ^b   Banik, Naren L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Akt; Caspase; Estrogen; IFN ; Motoneurons; PTEN

Indexed keywords

CALPAIN; CASPASE 3; ESTROGEN; GAMMA INTERFERON; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; MOTONEURON; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPINAL CORD INJURY;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; ESTRADIOL; ESTROGENS; INTERFERON-GAMMA; MICE; MOTOR NEURONS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; PTEN PHOSPHOHYDROLASE; RATS; SIGNAL TRANSDUCTION; SPINAL CORD;

EID: 71849117415     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.09.016     Document Type: Article

References (39)

1. Backman S., Stambolic V., and Mak T. PTEN function in mammalian cell size regulation. Curr. Opin. Neurobiol. 12 (2002) 516-522
2. Bellacosa A., Kumar C.C., Di Cristofano A., and Testa J.R. Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv. Cancer Res. 94 (2005) 29-86
3. Cantley L.C., and Neel B.G. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 4240-4245
4. Chang N., El-Hayek Y.H., Gomez E., and Wan Q. Phosphatase PTEN in neuronal injury and brain disorders. Trends Neurosci. 30 (2007) 581-586
5. Choi Y.C., Lee J.H., Hong K.W., and Lee K.S. 17 Beta-estradiol prevents focal cerebral ischemic damages via activation of Akt and CREB in association with reduced PTEN phosphorylation in rats. Fundam. Clin. Pharmacol. 18 (2004) 547-557
6. Choi C.I., Lee Y.D., Gwag B.J., Cho S.I., Kim S.S., and Suh-Kim H. Effects of estrogen on lifespan and motor functions in female hSOD1 G93A transgenic mice. J. Neurol. Sci. 268 (2008) 40-47
7. Crawford Jr. G.D., Le W.D., Smith R.G., Xie W.J., Stefani E., and Appel S.H. A novel N18TG2 × mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin. J. Neurosci. 12 (1992) 3392-3398
8. Das A., Banik N.L., Patel S.J., and Ray S.K. Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities. Mol. Cancer 3 (2004) 36
9. Datta S.R., Brunet A., and Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev 13 (1999) 2905-2927
10. Di Cristofano A., and Pandolfi P.P. The multiple roles of PTEN in tumor suppression. Cell 100 (2000) 387-390
11. Dimayuga F.O., Reed J.L., Carnero G.A., Wang C., Dimayuga E.R., Dimayuga V.M., Perger A., Wilson M.E., Keller J.N., and Bruce-Keller A.J. Estrogen and brain inflammation: effects on microglial expression of MHC, costimulatory molecules and cytokines. J. Neuroimmunol 161 (2005) 123-136
12. Garay L., Gonzalez Deniselle M.C., Gierman L., Meyer M., Lima A., Roig P., and De Nicola A.F. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Neuroimmunomodulation 15 (2008) 76-83
13. Gary D.S., and Mattson M.P. PTEN regulates Akt kinase activity in hippocampal neurons and increases their sensitivity to glutamate and apoptosis. Neuromol. Med 2 (2002) 261-269
14. Ji S.P., Zhang Y., Van Cleemput J., Jiang W., Liao M., Li L., Wan Q., Backstrom J.R., and Zhang X. Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse. Nat. Med. 12 (2006) 324-329
15. Jia J., Guan D., Zhu W., Alkayed N.J., Wang M.M., Hua Z., and Xu Y. Estrogen inhibits Fas-mediated apoptosis in experimental stroke. Exp. Neurol. 215 (2009) 48-52
16. Lachyankar M.B., Sultana N., Schonhoff C.M., Mitra P., Poluha W., Lambert S., Quesenberry P.J., Litofsky N.S., Recht L.D., Nabi R., Miller S.J., Ohta S., Neel B.G., and Ross A.H. A role for nuclear PTEN in neuronal differentiation. J. Neurosci. 20 (2000) 1404-1413
17. Leslie N.R., Yang X., Downes C.P., and Weijer C.J. The regulation of cell migration by PTEN. Biochem. Soc. Trans. 33 (2005) 1507-1508
18. Li L., Liu F., and Ross A.H. PTEN regulation of neural development and CNS stem cells. J. Cell. Biochem. 88 (2003) 24-28
19. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S.H., Giovanella B.C., Ittmann M., Tycko B., Hibshoosh H., Wigler M.H., and Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275 (1997) 1943-1947
20. Li L., Liu F., Salmonsen R.A., Turner T.K., Litofsky N.S., Di Cristofano A., Pandolfi P.P., Jones S.N., Recht L.D., and Ross A.H. PTEN in neural precursor cells: regulation of migration, apoptosis, and proliferation. Mol. Cell. Neurosci. 20 (2002) 21-29
21. Marsh D.J., Coulon V., Lunetta K.L., Rocca-Serra P., Dahia P.L., Zheng Z., Liaw D., Caron S., Duboue B., Lin A.Y., Richardson A.L., Bonnetblanc J.M., Bressieux J.M., Cabarrot-Moreau A., Chompret A., Demange L., Eeles R.A., Yahanda A.M., Fearon E.R., Fricker J.P., Gorlin R.J., Hodgson S.V., Huson S., Lacombe D., Eng C., et al. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum. Mol. Genet. 7 (1998) 507-515
22. Moosmann B., and Behl C. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 8867-8872
23. Morissette M., Al Sweidi S., Callier S., and Di Paolo T. Estrogen and SERM neuroprotection in animal models of Parkinson's disease. Mol. Cell. Endocrinol. 290 (2008) 60-69
24. Myers M.P., Pass I., Batty I.H., Van der Kaay J., Stolarov J.P., Hemmings B.A., Wigler M.H., Downes C.P., and Tonks N.K. The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 13513-13518
25. Nath R., Raser K.J., Stafford D., Hajimohammadreza I., Posner A., Allen H., Talanian R.V., Yuen P., Gilbertsen R.B., and Wang K.K. Non-erythroid α-spectrin breakdown by calpain and interleukin-1Δ-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis. Biochem. J. 319 Pt. 3 (1996) 683-690
26. Omori N., Jin G., Li F., Zhang W.R., Wang S.J., Hamakawa Y., Nagano I., Manabe Y., Shoji M., and Abe K. Enhanced phosphorylation of PTEN in rat brain after transient middle cerebral artery occlusion. Brain Res. 954 (2002) 317-322
27. Ray S.K., Wilford G.G., Crosby C.V., Hogan E.L., and Banik N.L. Diverse stimuli induce calpain overexpression and apoptosis in C6 glioma cells. Brain Res. 829 (1999) 18-27
28. Ray S.K., Wilford G.G., Matzelle D.C., Hogan E.L., and Banik N.L. Calpeptin and methylprednisolone inhibit apoptosis in rat spinal cord injury. Ann. N. Y. Acad. Sci. 890 (1999) 261-269
29. Sano T., Lin H., Chen X., Langford L.A., Koul D., Bondy M.L., Hess K.R., Myers J.N., Hong Y.K., Yung W.K., and Steck P.A. Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. Cancer Res. 59 (1999) 1820-1824
30. Smith R.G., Alexianu M.E., Crawford G., Nyormoi O., Stefani E., and Appel S.H. Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 3393-3397
31. Sribnick E.A., Ray S.K., and Banik N.L. Estrogen as a multi-active neuroprotective agent in traumatic injuries. Neurochem. Res. 29 (2004) 2007-2014
32. Sribnick E.A., Matzelle D.D., Ray S.K., and Banik N.L. Estrogen treatment of spinal cord injury attenuates calpain activation and apoptosis. J. Neurosci. Res. 84 (2006) 1064-1075
33. 2+ influx through L-type voltage-gated Ca2+ channels. Brain Res. 1276 (2009) 159-170
34. Steck P.A., Pershouse M.A., Jasser S.A., Yung W.K., Lin H., Ligon A.H., Langford L.A., Baumgard M.L., Hattier T., Davis T., Frye C., Hu R., Swedlund B., Teng D.H., and Tavtigian S.V. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15 (1997) 356-362
35. Veldink J.H., Bär P.R., Joosten E.A., Otten M., Wokke J.H., and van den Berg L.H. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul. Disord. 13 (2003) 737-743
36. Wang K.K., Posmantur R., Nath R., McGinnis K., Whitton M., Talanian R.V., Glantz S.B., and Morrow J.S. Simultaneous degradation of alphaII- and betaII-spectrin by caspase 3 (CPP32) in apoptotic cells. J. Biol. Chem. 273 (1998) 22490-22497
37. Wilson M.E., Liu Y., and Wise P.M. Estradiol enhances Akt activation in cortical explant cultures following neuronal injury. Mol. Brain Res. 102 (2002) 48-54
38. Xu J., Yeon J.E., Chang H., Tison G., Chen G.J., Wands J., and de la Monte S. Ethanol impairs insulin-stimulated neuronal survival in the developing brain: role of PTEN phosphatase. J. Biol. Chem. 278 (2003) 26929-26937
39. Yeon J.E., Califano S., Xu J., Wands J.R., and De La Monte S.M. Potential role of PTEN phosphatase in ethanol-impaired survival signaling in the liver. Hepatology 38 (2003) 703-714